1. Bigenzahn, Johannes W, Collu, Giovanna M, Kartnig, Felix, Mlodzik, Marek, Superti-Furga, Giulio. 2018. LZTR1 is a regulator of RAS ubiquitination and signaling. In Science (New York, N.Y.), 362, 1171-1177. doi:10.1126/science.aap8210. https://pubmed.ncbi.nlm.nih.gov/30442766/
2. Farncombe, Kirsten M, Thain, Emily, Barnett-Tapia, Carolina, Sadeghian, Hamid, Kim, Raymond H. 2022. LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis. In BMC medical genomics, 15, 160. doi:10.1186/s12920-022-01304-x. https://pubmed.ncbi.nlm.nih.gov/35840934/
3. Piotrowski, Arkadiusz, Xie, Jing, Liu, Ying F, Korf, Bruce R, Messiaen, Ludwine M. 2013. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. In Nature genetics, 46, 182-7. doi:10.1038/ng.2855. https://pubmed.ncbi.nlm.nih.gov/24362817/
4. Pagnamenta, Alistair T, Kaisaki, Pamela J, Bennett, Fenella, Taylor, Jenny C, Stewart, Helen. 2019. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome. In Clinical genetics, 95, 693-703. doi:10.1111/cge.13533. https://pubmed.ncbi.nlm.nih.gov/30859559/
5. . . Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. In Cell, 169, 1327-1341.e23. doi:10.1016/j.cell.2017.05.046. https://pubmed.ncbi.nlm.nih.gov/28622513/